IRVINE, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic diagnostics and screening, miscarriage analysis, prenatal and pediatric diagnostics, announces that that management will present at two upcoming investment conferences:
- 2016 Marcum MicroCap Conference on June 2nd, 2016 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time). The conference is being held at the Grand Hyatt Hotel in New York City.
- LD Micro Invitational on June 9th at 9:00 a.m. Pacific time (12:00 p.m. Eastern time). The conference is being held at the Luxe Sunset Hotel in Los Angeles.
A live webcast of the presentation from the Marcum Microcap Conference will be available on the company’s website at http://investor.combimatrix.com/events.cfm and will be archived for 30 days.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in pre-implantation genetic screening, miscarriage analysis, prenatal and pediatric diagnostics, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. CombiMatrix is dedicated to providing high-level clinical support for healthcare professionals in order to help them incorporate the results of complex genetic testing into patient-centered medical decision making. Additional information about CombiMatrix is available at www.combimatrix.com or by calling (800) 710-0624.
|Company Contact:||Investor Relations Contact:|
|President & CEO, CombiMatrix Corporation||Jody Cain|
|(949) 753-0624||(310) 691-7100|